These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28991918)

  • 1. Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial.
    Pernica JM; Steenhoff AP; Mokomane M; Moorad B; Lechiile K; Smieja M; Mazhani L; Cheng J; Kelly MS; Loeb M; Stordal K; Goldfarb DM
    PLoS One; 2017; 12(10):e0185177. PubMed ID: 28991918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimising the management of childhood acute diarrhoeal disease using a rapid test-and- treat strategy and/or
    Pernica JM; Arscott-Mills T; Steenhoff AP; Mokomane M; Moorad B; Bapabi M; Lechiile K; Mangwegape O; Batisani B; Mawoko N; Muthoga C; Vanniyasingam T; Ewusie J; Lowe A; Bonsu JM; Gezmu AM; Smieja M; Mazhani L; Stordal K; Thabane L; Kelly MS; Goldfarb DM
    BMJ Glob Health; 2022 Apr; 7(4):. PubMed ID: 35418412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an Oral Rehydration Solution Enriched with
    Maragkoudaki M; Chouliaras G; Moutafi A; Thomas A; Orfanakou A; Papadopoulou A
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30200394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea--a double-blind study.
    Francavilla R; Lionetti E; Castellaneta S; Ciruzzi F; Indrio F; Masciale A; Fontana C; La Rosa MM; Cavallo L; Francavilla A
    Aliment Pharmacol Ther; 2012 Aug; 36(4):363-9. PubMed ID: 22680836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children.
    Dinleyici EC; ; Vandenplas Y
    Acta Paediatr; 2014 Jul; 103(7):e300-5. PubMed ID: 24579935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial.
    Kołodziej M; Szajewska H
    BMJ Open; 2017 Jan; 7(1):e013928. PubMed ID: 28057659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children.
    Urbańska M; Gieruszczak-Białek D; Szajewska H
    Aliment Pharmacol Ther; 2016 May; 43(10):1025-34. PubMed ID: 26991503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting.
    Dinleyici EC; Dalgic N; Guven S; Metin O; Yasa O; Kurugol Z; Turel O; Tanir G; Yazar AS; Arica V; Sancar M; Karbuz A; Eren M; Ozen M; Kara A; Vandenplas Y
    J Pediatr (Rio J); 2015; 91(4):392-6. PubMed ID: 25986615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: a randomized clinical trial.
    Kołodziej M; Szajewska H
    Clin Microbiol Infect; 2019 Jun; 25(6):699-704. PubMed ID: 30149135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of Efficacy of Lactobacillus reuteri DSM 17938 for the Treatment of Acute Gastroenteritis: A Randomized Controlled Trial.
    Szymański H; Szajewska H
    Pediatr Infect Dis J; 2019 Oct; 38(10):e237-e242. PubMed ID: 31033909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol.
    ABCD study team
    Trials; 2020 Jan; 21(1):71. PubMed ID: 31931848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children.
    Szajewska H; Urbańska M; Chmielewska A; Weizman Z; Shamir R
    Benef Microbes; 2014 Sep; 5(3):285-93. PubMed ID: 24463209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial.
    Pernica JM; Steenhoff AP; Mokomane M; Moorad B; Lechiile K; Smieja M; Mazhani L; Cheng J; Kelly MS; Loeb M; Stordal K; Goldfarb DM
    PLoS One; 2018; 13(3):e0194957. PubMed ID: 29561910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults.
    Cimperman L; Bayless G; Best K; Diligente A; Mordarski B; Oster M; Smith M; Vatakis F; Wiese D; Steiber A; Katz J
    J Clin Gastroenterol; 2011 Oct; 45(9):785-9. PubMed ID: 21552138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which Probiotic Is the Most Effective for Treating Acute Diarrhea in Children? A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
    Li Z; Zhu G; Li C; Lai H; Liu X; Zhang L
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oral preparation of Lactobacillus acidophilus for the treatment of uncomplicated acute watery diarrhoea in Vietnamese children: study protocol for a multicentre, randomised, placebo-controlled trial.
    Kolader ME; Vinh H; Ngoc Tuyet PT; Thompson C; Wolbers M; Merson L; Campbell JI; Ngoc Dung TT; Manh Tuan H; Vinh Chau NV; Farrar J; van Doorn HR; Baker S
    Trials; 2013 Jan; 14():27. PubMed ID: 23356823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of Lactobacillus Reuteri DSM 17938 in Healthy Children 2-5 Years of Age.
    Kosek MN; Peñataro-Yori P; Paredes-Olortegui M; Lefante J; Ramal-Asayag C; Zamora-Babilonia M; Meza-Sanchez G; Oberhelman RA
    Pediatr Infect Dis J; 2019 Aug; 38(8):e178-e180. PubMed ID: 30531312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and microbiological evaluation of the effect of Lactobacillus reuteri in the treatment of mucositis and peri-implantitis: A triple-blind randomized clinical trial.
    Galofré M; Palao D; Vicario M; Nart J; Violant D
    J Periodontal Res; 2018 Jun; 53(3):378-390. PubMed ID: 29352461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO).
    Barker AK; Duster M; Valentine S; Hess T; Archbald-Pannone L; Guerrant R; Safdar N
    J Antimicrob Chemother; 2017 Nov; 72(11):3177-3180. PubMed ID: 28961980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Lactobacillus reuteri DSM 17938 for the Prevention of Nosocomial Diarrhea in Children: A Randomized, Double-blind, Placebo-controlled Trial.
    Urbańska M; Gieruszczak-Białek D; Szymański H; Szajewska H
    Pediatr Infect Dis J; 2016 Feb; 35(2):142-5. PubMed ID: 26551445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.